Drugs / SQZ-AAC-HPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04892043 | Aug 2021 → Nov 2023 | — | SQZ Biotechnologies | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SQZ-AAC-HPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04892043 ↗ |
| Modality | Cell therapy | “Activating antigen carriers (AACs) cell therapy” NCT04892043 ↗ |